DMTK
Closed
Dermtech Inc
0.0365
-0.0050 (-12.05%)
Last Update: 29 Aug 2024 16:30:00
Yesterday: 0.0415
Day's Range: 0.0213 - 0.041
Send
sign up or login to leave a comment!
When Written:
3.68
DermTech Inc is a biotechnology company that specializes in the development of non-invasive diagnostic tests for skin diseases. The company was founded in 2010 and is headquartered in La Jolla, California. DermTech's proprietary technology, known as the "Pigmented Lesion Assay" (PLA), allows for the early detection of melanoma and other skin cancers by analyzing skin samples collected using an adhesive patch. The company also offers tests for other skin conditions, such as psoriasis and eczema. DermTech's products are designed to improve the accuracy and speed of diagnosis, while reducing the need for invasive procedures such as biopsies. The company is publicly traded on the NASDAQ under the ticker symbol DMTK.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








